Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 ...
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments ...
ANTG Inks Deal with Curaleaf to Supply Medical Cannabis for UK Patients
LONDON – Australian Natural Therapeutics Group, a leading cultivator of ...
Bioxyne Reports Record Revenue, Yet Cash Outflows Climb on Expansion Push
SYDNEY – Bioxyne Limited, an Australian life sciences and wellness ...
Lebanon Legalizes Cannabis, Forms Oversight Body, Targeting $1B in Annual Revenue
BEIRUT – In a significant step forward in leveraging its ...
Germany Boosts Medical Cannabis Import Cap
BERLIN – German health authorities have increased the annual limit ...
Manitoba Cannabis Sales Accelerate, Leaving Liquor in the Rearview
WINNIPEG – Cannabis revenues in Manitoba posted double-digit gains, handily ...
Australian Policy Group Cautions TGA on Medicinal Cannabis Restrictions, Fearing Shift to Illicit Sources
SYDNEY – A prominent drug policy organization in Australia has ...
Global Cannabis Market Tightens Amid Surging Demand and Supply Snags
LOS ANGELES – Germany's medical Cannabis imports jumped more than ...
Alternaleaf Rolls Out Targeted Cannabis Program for UK Women’s Health Issues
LONDON – Alternaleaf, the United Kingdom's online medical Cannabis clinic, ...
